COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,306 Articles (22,772 medRxiv, 8,534 bioRxiv)

Most recent first Previous |  Page 3017: Articles 30161-30170  | Next

Countrywide quarantine only mildly increased anxiety level during COVID-19 outbreak in China
Hu, W., Su, L., Qiao, J., Zhu, J., Zhou, Y.
10.1101/2020.04.01.20041186 — Posted: 2020-04-04
Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors Usage is Associated with Improved Inflammatory Status and Clinical Outcomes in COVID-19 Patients With Hypertension
Yang, G., Tan, Z., Zhou, L., Yang, M., Peng, L., Liu, J., Cai, J., Yang, R., Han, J., Huang, Y., He, S.
10.1101/2020.03.31.20038935 — Posted: 2020-04-04
Fatal toxicity of chloroquine or hydroxychloroquine with metformin in mice
Rajeshkumar, N. V., Yabuuchi, S., Pai, S. G., Maitra, A., Hidalgo, M., Dang, C. V.
10.1101/2020.03.31.018556 — Posted: 2020-04-04 Discussion: Onsite | Offsite
In-silico analysis of SARS-CoV-2 genomes: Insights from SARS encoded non-coding RNAs
Periwal, N., Sarma, S., Arora, P., Sood, V.
10.1101/2020.03.31.018499 — Posted: 2020-04-04 Discussion: Onsite
Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support
Gritti, G., Raimondi, F., Ripamonti, D., Riva, I., Landi, F., Alborghetti, L., Frigeni, M., Damiani, M., Mico, C., Fagiuoli, S., Cosentini, R., Luca Lorini, F., Fabretti, F., Morgan, J., Owens, B. M. J., Kanhai, K., Cowburn, J., Rizzi, M., Di Marco, F., Rambaldi, A.
10.1101/2020.04.01.20048561 — Posted: 2020-04-03 Discussion: Offsite
Perceptions and behavioural responses of the general public during the COVID-19 pandemic: A cross-sectional survey of UK Adults
Atchison, C. J., Bowman, L., Vrinten, C., Redd, R., Pristera, P., Eaton, J. W., Ward, H.
10.1101/2020.04.01.20050039 — Posted: 2020-04-03
Knowledge and Beliefs towards Universal Safety Precautions to flatten the curve during Novel Coronavirus Disease (nCOVID-19) Pandemic among general Public in India: Explorations from a National Perspective
Gudi, S. K., Undela, K., Venkataraman, R., Mateti, U. V., Chhabra, M., Nyamagoud, S., Tiwari, K. K.
10.1101/2020.03.31.20047126 — Posted: 2020-04-03 Discussion: Onsite | Offsite
The Effectiveness of Targeted Quarantine for Minimising Impact of COVID-19
Jamieson-Lane, A. D., Cytrnbaum, E.
10.1101/2020.04.01.20049692 — Posted: 2020-04-03
Intervention Serology and Interaction Substitution: Modeling the Role of 'Shield Immunity' in Reducing COVID-19 Epidemic Spread
Weitz, J. S., Beckett, S. J., Coenen, A. R., Demory, D., Dominguez-Mirazo, M., Dushoff, J., Leung, C.-Y., Li, G., Magalie, A., Park, S. W., Rodriguez-Gonzalez, R., Shivam, S., Zhao, C.
10.1101/2020.04.01.20049767 — Posted: 2020-04-03 Discussion: Offsite
Simple model for Covid-19 epidemics - back-casting in China and forecasting in the US
Hermanowicz, S. W.
10.1101/2020.03.31.20049486 — Posted: 2020-04-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).